Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
SLM-Axitinib-Pembrolizumab for Renal Cell Carcinoma
Recruiting1 awardPhase 1 & 2
Iowa City, Iowa
This trial is testing a new combination of drugs to see if it is safe and effective for patients with advanced kidney cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service